Answers are grounded in this paper and cite their sources.
Systematic review evaluates economic implications of non-invasive vs. invasive CAD diagnostics, suggesting potential benefits.
Aims While the clinical benefits of non-invasive modalities to diagnosis of coronary artery disease (CAD) are well recognized, the economic implications of their use over invasive options remain unclear. This review aims to understand the health economic consequences of using non-invasive versus invasive modalities in symptomatic patients with low-to-intermediate pre-test probability (PTP) of CAD, and to explore whether economic and humanistic data can inform future investment decisions around non-invasive and invasive diagnostic modalities.
No takes yet. Share an insight, caveat, or question.
Kluge et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: